17,881 resources
By Version
By Realm
Start Prev Rows 14000 - 14200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC | active | 2023-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.204 | Pregnancy Labs, Blood/Serum/Plasma/Urine | active | 2024-04 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.183 | Clomiphene (Selective Estrogen Receptor Modulator / SERM) | active | 2024-04 | us | rx | ||
hl7.fhir.us.core | R4 | us-core-screening-assessment-condition-category | US Core Screening Assessment Condition Category | trial-use | 3 | cgp | 2024-11 | us | fhir |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.31 | Healthcare Service Location Type Combined | active | 2025-05 | us | vsac | ||
hl7.terminology | R5 | yes-no-unknown-not-asked | Yes No Unknown NotAsked | active | 2020-06 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.460 | Cluster Headache (ICD10CM) | active | 2025-05 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.461 | Cluster Headache (ICD9CM) | active | 2025-05 | us | icd | ||
ca.on.oh-olis | R4 | olis-MicroorganismCodes | MicroorganismCodes | active | sct | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.467 | Medication Therapy for Cluster Headache (RXNORM) | active | 2025-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.91 | Rho(D) Immune Globulin | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.192 | Immunosuppressive Medication RxNorm | active | 2022-03 | us | rx | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-benefit-restriction | RTPBC Benefit Restriction Value Set | trial-use | 4 | phx | 2020-05 | us | fhir |
hl7.fhir.us.specialty-rx | R4 | specialty-rx-consent-status | Specialty Rx Value Set - Consent Status | active | 2020-12 | us | fhir | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-country-code | RTPBC Country Code Value Set | trial-use | 4 | phx | 2020-05 | us | iso |
ca.on.oh-olis | R4 | DiagnosisCodes | DiagnosisCodes | draft | fhir | ||||
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT | trial-use | 2 | pc | 2025-05 | us | sct loinc |
hl7.fhir.eu.hdr | R4 | sdoh-obs-snomed-loinc-eu-hdr | SDOH Observation codes | draft | 2025-06 | eu | sct loinc | ||
hl7.fhir.uv.pharm-quality | R5 | vs-country-pq | ISO Country two letter codes | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-batch-designation-pq | Batch Designation | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-closureTypes-pq | Closure Types | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-containerOrientation-pq | Container Orientations | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-deviceProperty-pq | Device Properties | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-diagramType-pq | Diagram Types | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-color-pq | Colors | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-impurity-origin-pq | Impurity Origins | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-impurity-type-pq | Impurity Types | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-ingredientFunction-pq | Ingredient Function | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-equipmentClass-pq | Equipment Classes | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufacturingParticipantRole-pq | Manufacturing Participant Role | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufacturingStepScale-pq | Manufacturing Step Scale | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufacturingStep-pq | Manufacturing Step | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-grade-pq | Grades | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-packageProperty-pq | Package Property | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-pharmaceutical-organization-type | Pharmaceutical Organization Type | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-planType-pq | Plan Type | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-reportType-pq | Report Type | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-processParameter-pq | Process Parameter | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-productSiteUtilizationType-pq | Product Site Utilization | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-characterizationStep-pq | Characterization Steps | active | brr | 2024-05 | uv | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-testCategory-pq | Test Category | active | brr | 2024-05 | uv | tho | |
hl7.fhir.us.pdmp | R4 | pdmp-rx-transmission-method | PDMP Value Set - Prescription Transmission Method | active | phx | 2024-04 | us | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-timePointDescription-pq | Time Point Description | active | brr | 2024-05 | uv | tho | |
hl7.fhir.us.pdmp | R4 | pdmp-species-type | PDMP Value Set - Species Type | active | phx | 2024-04 | us | tho | |
hl7.fhir.us.pdmp | R4 | pdmp-response-status | PDMP Value Set - Response Status | active | phx | 2024-04 | us | fhir tho | |
hl7.fhir.us.ecr | R4 | us-ph-pregnancy-status | US Public Health Pregnancy Status | active | pher | 2018-07 | us | vsac tho | |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-pregnancy-status | US Public Health VaueSet - Pregnancy Status | active | 2018-07 | us | vsac tho | ||
hl7.fhir.us.ecr | R4 | us-ph-valueset-priority | US Public Health ValueSet Priority | active | pher | 2018-07 | us | fhir | |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-priority | US Public Health ValueSet Priority | active | 2021-07 | us | fhir | ||
hl7.fhir.us.pdmp | R4 | pmix-method-of-payment | PDMP Value Set - Method of Payment | active | phx | 2024-04 | us | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.89 | D(Rh) Type | active | 2024-06 | us | sct | ||
hl7.fhir.us.ecr | R4 | valueset-ecr-messageheader-event | eCR MessageHeader Event Value Set | active | pher | 2025-03 | us | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-coded-race-and-ethnicity-person-vr | Coded Race and Ethnicity Person Vital Records | active | pher | 2025-05 | us | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-role-vr | Value Set - Role Vital Records | active | pher | 2025-05 | us | tho | |
hl7.fhir.us.pdmp | R4 | pdmp-opioid-treatment-code | PDMP Value Set - Opioid Treatment Code | active | phx | 2024-04 | us | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.81 | Estimated Date of Delivery Including Method | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.82 | Estimated Gestational Age Code Including Method | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.88 | Pregnancy Related Findings | active | 2024-06 | us | sct | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-patient-pay-type | RTPBC Patient Pay Type Value Set | trial-use | 4 | phx | 2020-05 | us | fhir |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.464 | Cluster Headache | active | 2023-12 | us | vsac | ||
fhir.cdc.opioid-cds-r4 | R4 | hospice-disposition | Hospice Disposition | active | 2023-05 | us | |||
hl7.fhir.us.core | R4 | us-core-specimen-condition | US Core Specimen Condition | trial-use | 2 | cgp | 2024-11 | us | vsac tho |
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-event-type | RTPBC Event Type Value Set | trial-use | 4 | phx | 2020-05 | us | fhir |
hl7.fhir.us.specialty-rx | R4 | specialty-rx-event-type | Specialty Rx Value Set - Event Type | active | 2020-05 | us | fhir | ||
hl7.fhir.us.mdi | R4 | vs-cremation-clearance-status | Cremation Clearance Status | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.us.mdi | R4 | vs-certified-workflow | Certified Workflow | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.us.mdi | R4 | vs-registration | Registration | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-deviceType-pq | Device Type | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-goalPriority-pq | Goal Priority | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufactured-item-property-pq | Manufactured Item Property | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.us.mdi | R4 | vs-med-dq-review | Medical Data Quality Review | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-qualifiedValueCriticality-pq | Qualified Value Criticality | active | brr | 2024-05 | uv | tho | |
hl7.fhir.us.mdi | R4 | vs-per-dq-review | Personal Data Quality Review | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-productNameType-pq | Product Name Type | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-specification-type-pq | Specification Type | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-substance-property-pq | Substance Property | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-substance-property-value-pq | Substance Property Value | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-test-method-pq | Test Method | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.us.mdi | R4 | vs-dcr-reason | Death Certificate Review Reason | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.us.mdi | R4 | vs-signature-status | Signature Status | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.us.mdi | R4 | vs-me-cert-affirmation | Medical Examiner Certification Status | trial-use | 3 | pher | 2025-07 | us | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-process-validation-procedure-pq | Process Validation Procedure | active | brr | 2024-05 | uv | fhir | |
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-pharmacy-type | RTPBC Pharmacy Type Value Set | trial-use | 4 | phx | 2020-05 | us | tho |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1123 | COVID_19 (Disorders) (ICD10CM) | active | 2023-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) | active | 2025-02 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) | active | 2024-01 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) | active | 2025-02 | us | loinc | ||
hl7.fhir.us.specialty-rx | R4 | specialty-rx-task-input-type | Specialty Rx Value Set - Task Input Type | active | 2023-01 | us | fhir | ||
hl7.fhir.us.specialty-rx | R4 | specialty-rx-task-output-type | Specialty Rx Value Set - Task Output Type | active | 2023-01 | us | fhir | ||
hl7.fhir.us.specialty-rx | R4 | specialty-rx-task-type | Specialty Rx Value Set - Task Type | active | 2023-01 | us | fhir | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-error-code | RTPBC Error Code Value Set | trial-use | 4 | phx | 2020-05 | us | tho |
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-billing-unit | RTPBC Billing Unit Value Set | trial-use | 4 | phx | 2020-05 | us | ucum |
hl7.fhir.fi.base | R4 | fi-base-register-identifier | Finnish ValueSet for systems of registry specifiers | draft | 2025-08 | fi | ietf | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-state-and-province-code | RTPBC Two Letter State and Province Code Value Set | trial-use | 4 | phx | 2020-05 | us | |
hl7.fhir.vn.core | R4 | vn-core-diagnosticreport-code | ValueSet for Diagnostic Report Code | draft | 2020-12 | vn | loinc | ||
signal.core.r4 | R4 | fips-county-co | CO FIPS Counties | draft | 2023-06 | us | tho | ||
hl7.fhir.uv.extensions.r3 | R3 | country | Country ValueSet | trial-use | 1 | fhir | 2023-03 | uv | iso |
hl7.terminology | R5 | jurisdiction | Jurisdiction ValueSet | active | 5 | vocab | 2024-02 | uv | iso |
hl7.terminology | R5 | insurance-coverage-type | Insurance Coverage Type | active | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | insurance-product-type | Insurance Product Type | active | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | insuranceplan-plan-type | Insuranceplan Plan Type | active | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | ndh-healthcare-service-category | NDH Healthcare Service Category | draft | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | ILRSpeakingSkillScale | Interagency Language Roundtable Speaking Skill Scale | active | 2 | pa | 2024-07 | uv | tho |
hl7.terminology | R5 | organization-alias-type | Organization Alias Type | draft | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | Languages | Languages | active | cgp | 2024-07 | uv | ietf | |
hl7.terminology | R5 | virtual-healthcare-delivery-method | Virtual Healthcare Delivery Method | draft | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | testscript-profile-destination-types | Test script profile destination type | active | 2 | fhir | 2024-04 | uv | tho |
hl7.terminology | R5 | testscript-profile-origin-types | Test script profile origin type | active | 2 | fhir | 2024-04 | uv | tho |
hl7.terminology | R5 | testscript-operation-codes | Test script operation code | draft | 2 | fhir | 2020-02 | uv | tho |
hl7.terminology.r4b | R4B | digital-certificate | Digital Certificate | draft | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | care-service-accessibility | Care Service Accessibility | active | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | diagnosis-role | DiagnosisRole | active | vocab | 2024-04 | uv | tho | |
signal.core.r4 | R4 | diagnosis-role | DiagnosisRole | draft | vocab | 2019-10 | us | tho | |
hl7.terminology | R5 | accepting-patients | Accepting Patients | active | 2 | pa | 2020-02 | uv | tho |
hl7.terminology | R5 | organization-affiliation-role | Organization Affiliation Role | active | 2 | pa | 2020-02 | uv | fhir tho |
hl7.terminology | R5 | encounter-diet | Diet | active | 1 | pa | 2024-04 | uv | tho |
signal.core.r4 | R4 | encounter-diet | Diet | draft | 1 | pa | 2019-10 | us | tho |
hl7.terminology | R5 | encounter-admit-source | Admit source | active | pa | 2024-04 | uv | tho | |
signal.core.r4 | R4 | encounter-admit-source | Admit source | draft | pa | 2019-10 | us | tho | |
signal.core.r4 | R4 | encounter-participant-type | Participant type | trial-use | 3 | pa | 2019-10 | us | tho |
ch.fhir.ig.ch-term | R4 | ch-core-encounter-participation-type | ChCoreEncounterParticipationType | active | 2020-04 | ch | fhir tho | ||
hl7.terminology | R5 | service-delivery-method | Service Delivery Method | active | 2 | pa | 2020-02 | uv | tho |
signal.core.r4 | R4 | encounter-special-courtesy | Special courtesy | draft | pa | 2019-10 | us | tho | |
hl7.terminology | R5 | encounter-class | Encounter class | active | 1 | pa | 2024-04 | uv | tho |
ee.hl7.fhir.base.r5 | R5 | ee-encounter-class | Encounter Class | draft | 2023-08 | ee | tho | ||
ee.fhir.terminology | R5 | encounter-class | Encounter Class | active | 2025-06 | ee | tho | ||
hl7.terminology | R5 | encounter-special-arrangements | Special arrangements | active | pa | 2024-04 | uv | tho | |
signal.core.r4 | R4 | encounter-special-arrangements | Special arrangements | draft | pa | 2019-10 | us | tho | |
hl7.terminology | R5 | referencerange-meaning | Observation Reference Range Meaning Codes | active | 0 | oo | 2024-04 | uv | tho |
signal.core.r4 | R4 | referencerange-meaning | Observation Reference Range Meaning Codes | trial-use | 0 | oo | 2019-10 | us | tho |
signal.core.r4 | R4 | referencerange-appliesto | Observation Reference Range Applies To Codes | draft | 1 | oo | 2019-10 | us | sct tho |
hl7.fhir.fr.core | R4 | fr-core-vs-encounter-discharge-disposition | FR Core ValueSet Encounter discharge disposition | informative | 1 | fhir | 2024-09 | fr | internal tho |
hl7.terminology | R5 | encounter-discharge-disposition | Discharge disposition | active | 1 | pa | 2024-04 | uv | tho |
hl7.terminology | R5 | clinical-discharge-disposition | Clinical Discharge Disposition | active | 2022-07 | uv | tho | ||
hl7.fhir.uv.vhdir | R4 | primarysourcetype | VhDir Primary Source Validation Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplancostqualifier | VhDir Insurance Plan Cost Qualifier | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | primarysourcepush | VhDir Primary Source Push | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplanbenefittype | VhDir Insurance Plan Benefit Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | healthcareservice-characteristic | VhDir Healthcare Service Characteristic ValueSet | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplancostcategory | VhDir Insurance Plan Cost Category | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplanbenefitcosttype | VhDir Insurance Plan Benefit Cost Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplancosttype | VhDir Insurance Plan Cost Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | failureaction | VhDir Failure Action | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | primarysourcefailureaction | VhDir Primary Source Failure Action | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | healthcareservice-eligibility | VhDir Healthcare Service Eligibility ValueSet | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | primarysourcepushtype | VhDir Primary Source Push Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplangroupsize | VhDir Insurance Plan Group Size | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | insuranceplan-type | VhDir Insurance Plan Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | plan-type | VhDir Plan Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | benefit-type | VhDir Benefit Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | coverage-type | VhDir Coverage Type | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | primarysourcevalidationstatus | VhDir Primary Source Validation Status | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.vhdir | R4 | limit-unit | VhDir Limit Unit | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.terminology | R5 | service-type | Service type | active | 1 | pa | 2024-04 | uv | tho |
signal.core.r4 | R4 | service-type | Service type | draft | 1 | pa | 2019-10 | us | tho |
hl7.terminology | R5 | service-category | Service category | active | 1 | pa | 2024-04 | uv | tho |
hl7.terminology | R5 | program | Program | active | 1 | pa | 2024-04 | uv | tho |
hl7.terminology | R5 | basic-resource-type | Basic Resource Types | active | 1 | fhir | 2024-04 | uv | tho |
hl7.fhir.us.breast-radiology | R4 | BreastImagingReportTypesVS | Breast Imaging Report Types ValueSet | active | 2022-12 | us | loinc | ||
hl7.fhir.vn.core | R4 | iso3166-1-2 | Iso 3166 Part 1: 2 Letter Codes | active | 2025-07 | vn | iso | ||
hl7.fhir.uv.vhdir | R4 | digitalcertificateuse | VhDir Digital Certificate Use Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.fhir.uv.extensions | R5 | language-preference-type | language preference type value set | trial-use | 3 | pa | 2025-08 | uv | fhir |
ee.tehik.mpi | R4 | eempi-education-level | EEMPI EducationLevel | active | 2022-10 | sct | |||
hl7.fhir.dk.core | R4 | dk-marital-status | DK MaritalStatus | active | 2025-02 | dk | internal fhir | ||
Test.Training | R3 | CareConnect-MaritalStatus-1 | Marital Status Codes | draft | 5 | pa | 2017-04 | fhir | |
NHSDigital.FHIR.STU3 | R3 | CareConnect-MaritalStatus-1 | Marital Status Codes | active | 5 | pa | 2017-04 | fhir | |
signal.core.r4 | R4 | questionnaire-dacods-marital-status | Questionnaire DACODS Marital Status | draft | 1 | pa | us | ||
hl7.fhir.us.qicore | R4 | qicore-negation-reason | QICore Negation Reason Codes | trial-use | 4 | cqi | 2018-12 | us | sct vsac |
ee.hl7.fhir.base.r4 | R4 | eebase-organization-internal-type | EEBase Organization Internal Type | normative | 0 | pa | 2022-05 | tho | |
ee.hl7.fhir.base.r4 | R4 | eebase-organization-type | EEBase Organization Type | normative | 0 | pa | 2022-05 | tho | |
signal.core.r4 | R4 | signal-program | Signal Program | draft | 1 | pa | us | ||
hl7.fhir.us.qicore | R4 | qicore-positive-event-status | Positive Event Status | trial-use | 4 | cqi | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-positive-medication-admin-status | Positive MedicationAdministration Status | trial-use | 4 | cqi | 2018-12 | us | tho |
hl7.fhir.us.qicore | R4 | qicore-positive-medicationdispense-status | Positive MedicationDispense Status | trial-use | 4 | cqi | 2018-12 | us | tho |
hl7.fhir.us.qicore | R4 | qicore-positive-medicationrequest-status | Positive MedicationRequest Status | trial-use | 4 | cqi | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-positive-request-status | Positive Request Status | trial-use | 4 | cqi | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-positive-task-status | Positive Task Status | trial-use | 4 | cqi | 2018-12 | us | fhir |
careconnect.stu3.03.00.00 | R3 | CareConnect-InterpretationCode-1 | Care Connect Extended Interpretation Code | draft | 2019-03 | ||||
hl7.fhir.us.carin-bb | R4 | CMSMS3MAPAPRDRG | MS-DRGs - AP-DRGs - APR-DRGs Value Set | trial-use | fm | 2025-02 | us | cms | |
hl7.terminology | R5 | USPS-State | USPS Two Letter Alphabetic Codes | active | 1 | cgp | 2025-05 | uv | |
signal.core.r4 | R4 | us-core-usps-state | USPS Two Letter Alphabetic Codes | active | 2022-09 | us | |||
ee.hl7.fhir.base.r4 | R4 | eebase-actpriority | EEBase ActPriority | draft | 2022-09 | tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.2000.1 | Percutaneous Coronary Intervention ICD10 | active | 2018-05 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.2000.2 | Percutaneous Coronary Intervention SNOMEDCT | active | 2024-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.2000.3 | Percutaneous Coronary Intervention CPT | active | 2025-02 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.2000.4 | Percutaneous Coronary Intervention HCPCS | active | 2018-05 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.10901 | ParticipationType | active | 2024-06 | us | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.193 | Gender Dysphoria | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.194 | Gender Identity | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335 | Sleep Apnea | active | 2018-05 | us | icd | ||
hl7.fhir.vn.core | R4 | vn-core-observation-smokingstatus | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) | active | 2020-12 | vn | sct | ||
fhir.deep6.ai | R4 | deep-6-ai-dna-change-type | Deep 6 AI DNA Change Type Value Set | active | 2025-06 | us | fhir tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.99 | Gestational Diabetes | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.4.642.3.155 | Care Team Category | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.169 | Cardiac Surgery | active | 2025-01 | us | cpt | ||
hl7.fhir.us.core | R4 | us-core-diagnosticreport-report-and-note-codes | US Core Non Laboratory Codes | trial-use | 3 | cgp | 2022-09 | us | loinc |
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1064 | Neurobehavioral Status Exam (CPT) | active | 2019-03 | us | cpt | ||
hl7.terminology | R5 | claim-type | Claim Type Codes | active | 2 | fm | 2024-04 | uv | tho |